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Sensitization to inflammatory pain is a pathological form of
neuronal plasticity that is poorly understood and treated. Here
we examine the role of the SH3 domain of postsynaptic density
95 (PSD95) by using mice that carry a single amino-acid
substitution in the polyproline-binding site. Testing multiple
forms of plasticity we found sensitization to inflammation was
specifically attenuated. The inflammatory response required
recruitment of phosphatidylinositol-3-kinase-C2a to the SH3-
binding site of PSD95. In wild-type mice, wortmannin or peptide
competition attenuated the sensitization. These results show that
different types of behavioural plasticity are mediated by specific
domains of PSD95 and suggest novel therapeutic avenues for
reducing inflammatory pain.
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INTRODUCTION
Plasticity in different regions of the central nervous system
underlies a diverse set of behaviours and pathologies. At
excitatory synapses, the scaffolding molecule postsynaptic density
95 (PSD95) assembles signalling complexes with glutamate
receptors and couples them to intracellular pathways mediating
synaptic and neuronal changes (Migaud et al, 1998; Komiyama
et al, 2002; Fernandez et al, 2009). Previous studies of mice
lacking PSD95 show alterations in multiple forms of experience-
dependent plasticity (Migaud et al, 1998; Komiyama et al, 2002;
Fagiolini et al, 2003; Yao et al, 2004) including sensory processing
(Garry et al, 2003). As the structure of PSD95 includes many
protein interaction domains—three PDZ, a single SH3 and a single
GK domain—it is possible that each domain controls specific
behaviours by recruiting specific protein-binding partners. To
investigate this issue we engineered a point mutation into the SH3
domain of PSD95 in mice and examined multiple forms of
behavioural plasticity.
RESULTS AND DISCUSSION
Using X-ray crystallographic data of several SH3 domains
(Musacchio et al, 1992, 1994; Noble et al, 1993; Borchert et al,
1994; Guruprasad et al, 1995), we engineered a mutation that
abrogates binding of proline-rich ligands (Lim & Richards, 1994;
Erpel et al, 1995; Mayer & Eck, 1995). Trp 470 of PSD95
corresponds to the highly conserved tryptophan residue found in
the hydrophobic binding surface of prototypical SH3 domains
that mediates interaction with proline-containing peptides
(Erpel et al, 1995). Leucine was substituted for this tryptophan
in vivo using gene targeting, creating the PSD95SH3W470L line
of mice (Fig 1A,B). Homozygous PSD95SH3W470L mice were
fertile, showed normal Mendelian transmission, no obvious
seizures, tremor, ataxia or other overt neurological abnormality,
nor any discernible defects in gross neuroanatomy as determined
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histologically (data not shown). Here, all mutant mice are
homozygous and are compared with wild-type (wt) littermates.
PSD95 protein expression was examined in PSD95SH3W470L
mutants by immunoblot analysis of mouse hippocampus and
spinal cord extracts using a PSD95 antibody raised against the
amino-terminus of the protein (Fig 1C). The expected full-length
(B95 kDa) PSD95 polypeptide was recognized at similar levels
in both wt and PSD95SH3W470L mutant extracts. PSD95 binds
to N-methyl-D-aspartate (NMDA) receptors through its first and
second PDZ domains and we therefore tested the levels
and association of NMDA receptor subunits. No detectable
differences in NR1, NR2A and NR2B expression in either
hippocampus or spinal cord extracts were found in
PSD95SH3W470L mutants as compared with wt animals (Fig 1D).
The PSD95SH3W470L mutant protein immunoprecipitated with
NR2B to the same extent as wt PSD95 (Fig 1E), indicating that the
mutant protein was normally folded and localized.
The most well-studied form of neuronal plasticity is long-term
potentiation (LTP) in the hippocampus. Mice lacking PSD95 have
severe impairments in LTP and we therefore tested the
PSD95SH3W470L mice in this assay (Fig 2). As shown in Fig 2, we
tested two forms of LTP using conventional high- or low-frequency
protocols (100 and 5Hz, respectively) and both of these were
unaffected by the SH3 mutation. We therefore conclude that
PSD95-mediated plasticity in the hippocampus does not require
binding of ligands to the SH3 domain.
As PSD95 is known to have an important role in spinal cord
plasticity (Garry et al, 2003), we examined sensitization to tissue
inflammation and nerve injury. Chronic constriction injury to the
peripheral nerve produces a sensitized state (reduced withdrawal
latency to a noxious thermal stimulus), which was unaffected
in the PSD95SH3W470L mice (Fig 3A). We next induced an
inflammatory injury (injection of complete Freund’s adjuvant,
CFA), which in wt mice after 24 h leads to the development of
sensitization (Fig 3B,D). In PSD95SH3W470L mice, sensitivity to
thermal and mechanical stimuli was completely abrogated
(Fig 3C,E). Similar results were obtained using formalin as a
further inflammatory stimulus (Fig 3F). These behavioural studies
show the PSD95 SH3 domain has an essential and specific role in
the sensitized response to tissue inflammation.
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Fig 1 | Construction of PSD95 SH3 point mutation in mice. (A) The top panel shows domain organization of PSD95 protein and the location of the
point mutation. The lower three diagrams represent wt genomic DNA, the targeting vector and the targeted allele after excision of the selection
cassette. Restriction enzyme sites: EI, EcoRI; EV, EcoRV; Sa, SacI; Sp, SpeI; Xb, XbaI; Xh, XhoI. Filled boxes, exons; asterisk, point mutation; neo and
tk, neomycin and thymidine kinase genes; arrowheads, loxP sites; DT-A, diphtheria toxin-A cassette. (B) Southern blot of EcoRV-digested genomic
DNA using a 50 probe. Lane 1, wt; lane 2, cassette intact; lane 3, cassette excised. (C) PSD95 levels in the hippocampus (HC) and spinal cord (SC)
of wt and mutant mice. (D) Immunoblots of NR1, NR2A and NR2B subunits of the NMDA receptor in wt and mutant mice in the HC and SC.
Densitometric analysis of samples showed no significant differences (n¼ 6, Student’s t-test) (data not shown). (E) Co-immunoprecipitation of NR2B
with PSD95 in hippocampal extracts shows the mutation does not affect association and thus the protein is folded. The input control is from wt mice
indicating the correct molecular weight. NMDA, N-methyl-D-aspartate; NR, NMDA receptor; PSD95, postsynaptic density 95; wt, wild type.
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To identify the molecular mechanism, we focused on the
binding specificity of the SH3 domain and the possibility that
particular proteins in the spinal cord interact with PSD95 through
this domain. We probed 9,000 16-amino-acid-long peptide
sequences, which encompassed the consensus SH3 ligand
sequence (PxxP) immobilized on glass slides ( Jerini SH3-domain
profiler detector peptide arrays) using a Cy5-labelled recombinant
SH3 domain of PSD95 (supplementary Table S1 online). Among
the strongest signals was the FPLWKLPGFPNRMVLG peptide from
phosphatidylinositol-3-kinase-C2a (PI(3)K-C2a), a signalling mol-
ecule of the PI(3)K family, previously implicated in inflammatory
processes (Foster et al, 2003; Pezet et al, 2008).
We next asked whether PI(3)K-C2a bound to PSD95 in the
spinal cord and if association was increased with inflammatory
sensitization. This was indeed the case and, importantly, recruit-
ment of PI(3)K-C2a to PSD95 was absent in PSD95SH3W470L
mutants. As shown in Fig 3G in wt mice, immunoprecipitation of
PSD95 complexes recovered PI(3)K-C2a after inflammatory
sensitization. In PSD95SH3W470L mutant mice this association
was undetectable. Because this suggests that the activity of
PI(3)K-C2a is required for inflammatory sensitization, wortmannin
(a PI(3)K-C2a inhibitor; Wang et al, 2006) was administered
intrathecally into wt mice and found to reverse sensitization
(Fig 3H). To test if recruitment to PSD95 during the inflammatory
response was required, we injected a peptide mimicking
the PI(3)K-C2a SH3 target motif, which could compete with
PI(3)K-C2a binding (and compared it with a control peptide
lacking three principal proline residues replaced by alanine). The
PI(3)K-C2a peptide prevented the sensitization after inflammation
in wt mice, and as expected it did not affect sensitization to nerve
injury (Fig 3I,J). The control peptide had no effect (Fig 3I,J).
These results show that peripheral tissue damage produces a
neuronal response in the spinal cord involving recruitment of
PI(3)K-C2a to the SH3 domain of PSD95. Blocking this recruit-
ment with either a mutation or a peptide competitor abrogates the
anticipated sensitized response, as does administration of a PI(3)K-
C2a inhibitor. These data indicate that this recruitment is
specifically required for inflammatory pain sensitization and not
for two other forms of plasticity: peripheral nerve injury or
hippocampus LTP. Furthermore, these other two forms of plasticity
are impaired when the entire PSD95 is knocked out (Migaud et al,
1998; Fagiolini et al, 2003; Garry et al, 2003; Yao et al, 2004),
indicating that specific domains of PSD95 have roles in specific
forms of behaviour. The SH3-mediated recruitment of PI(3)K-C2a
allows it to act in close proximity to other proteins binding to
PSD95, including NR2B, calcium calmodulin kinase II and
extracellular signal-regulated kinase, which are also involved in
inflammatory responses.
Previous studies have shown that the signalling complexes
associated with neurotransmitter receptors such as the NMDA
receptor complex are composed of many proteins that are
differentially expressed within the nervous system (Husi et al,
2000; Komiyama et al, 2002; Cuthbert et al, 2007; Emes
et al, 2008; Fernandez et al, 2009). Differences in the composition
of complexes between adaptor molecules and other proteins,
mediated by specific protein interaction domains, could underlie
different types of synaptic plasticity found in distinct types of
neuron. Moreover, genetic disruption of these complexes in
experimental animals and in heritable diseases will therefore alter
plasticity to pain responses and other environmental responses
including learning and memory (Migaud et al, 1998; Komiyama
et al, 2002; Grant et al, 2005). Understanding the assembly of
specific signalling complexes at different synapses might allow the
development of therapeutics that target particular classes of
synapse. The current studies suggest that PI(3)K-C2a is a potential
drug target for inflammatory pain.
METHODS
Gene targeting. The PSD95SH3W470L targeting vector comprised
two homology arms of genomic DNA (3.8 kb NotI–SpeI and 6.2 kb
SpeI–XhoI fragments) flanking a floxed cassette containing
neomycin and thymidine kinase selectable markers within a
diphtheria toxin-A vector. A tryptophan-to-leucine amino-acid
change (W470L) incorporating a SacI restriction site was
introduced using the Stratagene Quik-Change Mutagenesis kit.
The linearized targeting vector was transfected into embryonic
stem (ES) cells (E14Tg2a clone), neomycin-resistant colonies were
picked and subsequently transfected with Cre recombinase to
excise the floxed cassette. Positive PSD95SH3W470L clones (with a
targeting efficiency of 4%) were identified by Southern blot
analysis: gels containing 20 mg of EcoRV- or SacI-digested
genomic DNA were blotted and probed with a 700-bp internal
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Fig 2 | Hippocampus synaptic plasticity unaltered in PSD95SH3W470L
mutant mice. Conventional 100Hz (top) and 5Hz (bottom), high-
frequency and low-frequency respectively, protocols were used that
induce NMDA receptor-dependent LTP of synaptic transmission, which
is greatly enhanced in PSD95-knockout mice (Migaud et al, 1998). We
found no phenotype in PSD95SH3W470L mice (mean and s.e.m., n¼ 4).
Open symbols, wt; closed symbols, PSD95SH3W470L mice. LTP, long-term
potentiation; NMDA, N-methyl-D-aspartate.
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and a 400-bp 50 probe. Positive clones were injected into mouse
blastocysts that were in turn inserted into recipient C57/Bl6
females. The resulting chimeric offspring were crossed onto the
MF1 background for subsequent studies. Mice were genotyped
at weaning by PCR using the following primers: forward primer
50-CCGACTGCTCACTAGTATTTTCTCCC-30 with reverse primer
50-CTTGGCCTTTAAACTAGTCCACTCTCGT-30. Wt and mutant
alleles were distinguished by digesting the resulting 1,400-bp
fragment with SacI to produce 1,000- and 400-bp mutant
fragments. From 29 PSD95SH3W470L litters, 128 pups were
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Fig 3 | PI(3)K-C2a recruitment to PSD95 SH3 domain is required for inflammatory responses. (A) Development of ipsilateral (‘i’) thermal hyperalgesia
as compared with the contralateral side (‘c’) after unilateral chronic constriction injury to the sciatic nerve occurred to a similar extent in wt and
PSD95SH3W470L mice (*Po0.05, Student’s paired t-test, n¼ 5–7). (B,D) Wt mice developed ipsilateral thermal hyperalgesia (B) and mechanical
allodynia (D) 24 h after inflammation evoked by hind-paw administration of CFA (*Po0.05, paired Student’s t-test for thermal data and Wilcoxon test
for mechanical data, n¼ 4), but this was prevented (C,E) in PSD95SH3W470L mutant mice (wPo0.05, Student’s t-test/Wilcoxon test, n¼ 4). (F) Ipsilateral
nocifensive responses taken over 25- to 40-min time points after administration of the noxious agent formalin by intraplantar injection of the hind
paw were also significantly attenuated in PSD95SH3W470L mutants as compared with that in wt mice (wPo0.05, Student’s t-test, n¼ 8–9). Contralateral
responses were negligible in each case. (G) Spinal cord PSD95 immunoprecipitates from wt and PSD95SH3W470L mice ipsilateral (‘i’) and contralateral
(‘c’) to formalin challenge were collected at 35–40min after formalin administration, in addition to naive groups (‘n’) and probed for PI(3)K-C2a
or PSD95 (n¼ 14 mice in each group). PI(3)K-C2a was strongly associated with PSD95 in wt spinal cord ipsilateral to the formalin challenge.
Densitometry from this and two further independent experimental groups shows ratios of PI(3)K-C2a/PSD95 were 0.053±0.007 (ipsilateral),
0.026±0.012 (contralateral) and 0.019±0.008 (naive) (means±s.e.m., Photoshop). PI(3)K-C2a was not detectable in control non-immune IgG
immunoprecipitates. By contrast, PSD95SH3W470L mice (or naive wt mice) showed no association of PI(3)K-C2a with PSD95 (mean PI(3)K-C2a/PSD95
ratios were less than 0.02). Equivalent levels of PSD95 were found in all wt and PSD95SH3W470L samples. (H) In wt mice, intrathecal injection of
wortmannin (7nmol in 10ml of saline with 1% dimethylformamide) reversed the enhancement of sensitivity to noxious thermal stimuli induced by CFA
observed in panel B (wPo0.05 compared with the ipsilateral side without wortmannin, Student’s t-test, n¼ 6). Previous studies have shown that this vehicle
alone has no effect on responses. (I) In wt mice, intrathecal injection of a myristoylated PI(3)K-C2a decoy peptide (but not a control peptide in which the
three key proline residues were replaced with alanine (1 nmol in 10ml of saline with 1% dimethylformamide)) reversed the enhanced sensitivity to noxious
thermal stimuli induced ipsilateral to CFA, but not CCI (*Po0.05 compared with the contralateral side, paired Student’s t-test, n¼ 6; wPo0.05 compared
with the ipsilateral side with control peptide, Student’s t-test, n¼ 6). (J) In wt mice, the intrathecal PI(3)K-C2a decoy peptide (but not control peptide)
attenuated the nocifensive responses ipsilateral to formalin (wPo0.05 compared with the ipsilateral side with control peptide, Student’s t-test, n¼ 6).
CCI, chronic constriction injury; CFA, complete Freund’s adjuvant; PI(3)K, phosphatidylinositol-3-kinase; wt, wild type.
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genotyped resulting in 43 wt (34%), 43 heterozygotes (34%) and
42 homozygotes (32%). Fertility was not affected in homozygotes
and no obvious seizure, tremor, ataxia or other overt neurological
abnormality observed.
Immunoprecipitation. Mouse hippocampal extracts were homo-
genized at 4 1C in 10 volumes of 1% sodium-deoxycholate, 1mM
NaF, 20mM ZnCl2, 0.5mM phenylmethylsulphonyl fluoride and
1mM Na3VO4 in 50mM Tris (pH 9.0) containing Complete
EDTA-free protein inhibitors (Roche, Mannheim, Germany).
Mouse spinal extracts were homogenized at 4 1C in 10 volumes
of phosphate-buffered saline containing 10% (v/v) glycerol, 1%
(w/v) CHAPS, 0.5% (w/v) sodium-deoxycholate, 1mM NaF, 1mM
Na3VO4, 5mM sodium-molybdate and 1:100 dilution Protease
Inhibitor Cocktail (Set III; Calbiochem, Darmstadt, Germany).
After centrifugation at 25,000 r.p.m. for 15min at 4 1C, 1mg
aliquots of hippocampal protein extract diluted in 1ml buffer were
incubated overnight at 4 1C with 4 mg of anti-PSD95 (Millipore,
Billerica, MA, USA). Immunocomplexes were captured using
40 ml of a 50% solution of G-protein-coupled Sepharose (Amer-
sham Pharmacia, Little Chalfont, Bucks, UK), incubated for 2 h at
4 1C followed by several washes in 1 lysis buffer. Spinal
homogenates were allowed to solubilize for 1.5 h at 4 1C with
rolling followed by centrifugation at 11,000 r.p.m. for 15min at
4 1C. The resultant supernatant was pre-cleared in 20 ml/ml
protein-G–Sepharose (Sigma, St Louis, MO, USA) for 1 h at 4 1C.
The pre-cleared supernatant was immunoprecipitated, for 16 h at
4 1C, using 3.5 mg/ml of mouse anti-PSD95 (75-028, NeuroMab/
Antibodies Inc., Davis, CA, USA) in the presence of 40 ml/ml
protein-G–Sepharose. Hippocampal immunocomplexes and/or
protein extracts (20 mg per lane) were separated by SDS–PAGE
and standard procedures were used for immunoblotting.
Immunoblotting. Hippocampal or spinal cord samples from wt
and mutant mice were homogenized in Laemmli buffer and
denatured at 100 1C for 5min. Proteins were separated by SDS–
PAGE electrophoresis on pre-cast 8% or 4–12% Bis–Tris Gels
(Invitrogen Life Technologies, Carlsbad, CA, USA). Blots were
probed with the following primary antibodies (spinal cord): NR1
(1:1,000; Millipore, or 1:100; Chemicon), NR2A (1:100; Upstate,
or 1:1,000; Transduction Labs, Lexington, KY, USA), NR2B
(1:100; Chemicon, or 1:250; Transduction Labs), PSD95
(1:10,000; Upstate, or Transduction Labs, UC Davis/NINDS/
NIMH NeuroMab Facility (75-028: clone K28/43, amino-terminal,
affinity purified; 1:100)) and mouse polyclonal PI(3)K-C2a
(H00005286-A01; Abnova, Walnut, CA, USA), and detected by
chemiluminescence. The specificity of the PI(3)K-C2a antibody
was confirmed by pre-absorption experiments with either a
glutathione-S-transferase (GST)-fusion protein of the antigenic
segment of PI(3)K-C2a (Abnova) or, as a control, a GST-fusion
protein of the small G-protein, RhoA (Cytoskeleton Inc., Denver,
CO, USA). The PI(3)K-C2a antibody (1:100 in phosphate-
buffered saline/0.1% Tween-20, 2% bovine serum albumin)
was incubated overnight with 3 mg of the antigen (partial
recombinant PI(3)K-C2a (1,577–1,687) as a GST-fusion protein
(Abnova) or GST-RhoA (Cytoskeleton Inc.) for 16 h at 4 1C with
rolling. A 25 ml of glutathione–Sepharose was added and samples
were incubated for 3 h at 4 1C with rolling before the beads
were removed by centrifugation (10,000 g, 10min, 4 1C) and
the supernatants were used directly for primary antibody
immunoblot incubations.
Peptide array interaction assays. Jerini SH3-domain profiler
detector peptide arrays ( Jerini Peptide Technologies, Gmbh,
Berlin, Germany) were used to analyse binding partners for
the PSD95 SH3 domain. Nine-thousand-peptide sequences,
16-amino-acids long, which encompassed the consensus SH3
ligand sequence -PxxP-, were synthesized on cellulose mem-
branes in a parallel manner using SPOT technology, deposited to
glass slides and covalently immobilized to the surface. A series of
positive and negative controls were also included. The glass slides
were incubated with different concentrations of the recombinant
PSD95 GST-SH3 domain (Panomics, FP3029) to obtain an
appropriate signal-to-noise ratio; a 0.2 mg/ml concentration was
selected for the array assays. For peptide array incubation, an
Abgene incubation chamber was used (AB-0630); the chamber
was previously treated with 0.1mg/ml of polyvinylpyrrolidone for
6 h. The arrays were incubated at 4 1C overnight, the chamber
removed, washed five times with distilled water and incubated 4 h
at 4 1C with Cy5 anti-GST, 1 mg/ml (PA92002, Amersham GE
Healthcare, Little Chalfont, Bucks, UK). Slides were washed five
times with distilled water and scanned at a 5 nm resolution using
ScanArray Express HT (Perkin-Elmer, Waltham, MA, USA). All of
the assays were performed in triplicate. Image analysis and signal
quantification were performed using ProscanArray Express (Per-
kin-Elmer) and positive signals were defined as significant
(Student’s t-test, Po0.001) after background subtraction was
compared against peptides without SH3 consensus sequences.
Peptides with positive signals were matched to the corresponding
proteins shown in supplementary Table S1 online.
In vivo peptide studies. As the peptide (FPLWKLPGFPNRMVLG)
encompassing the consensus proline-rich SH3 target site within
PI(3)K-C2a was a strong binding partner for the GST-PSD95 SH3
domain construct, we designed an N-myristoylated version of the
decoy peptide (myr-FPLWKLPGFPNRMVLG) together with a
control (myr-FALWKLAGFANRMVLG) in which all crucial proline
residues were substituted with alanine (Pepsyn Ltd, Liverpool,
UK). The peptides were freshly dissolved in dimethylformamide
(10mM) and diluted into sterile saline, acidified to pH 4.0–4.5
with HCl to form 100 mM solutions, which were then re-titrated
to pH 6.5 with dilute NaOH. Aliquots measuring 10 ml were
then injected intrathecally. Nociceptive responses were recorded
ipsilateral and contralateral to injury both before and after
intrathecal injection of peptides.
Chronic pain models. Peripheral nerve injury and formalin
challenges have been described previously together with all
assessment criteria (Garry et al, 2003). Formalin challenges were
characterized over the first (5–15min) and second (25–45min)
phases of the response. Inflammation using CFA was induced by
intraplantar injection of the hind paw, under brief halothane
anaesthesia (Chaplan et al, 1997). All behavioural and physiolo-
gical analyses were performed using male and female mice
ranging from 4 to 14 months of age. There were no differences in
responses between male and female mice.
Hippocampal synaptic plasticity. Hippocampal slice electrophy-
siology was performed as described previously (Komiyama et al,
2002). Briefly, 400 mm-thick hippocampal slices were prepared
from 14- to 20-week-old mice using standard techniques.
The slices were maintained in an interface-type recording
chamber perfused (1–3ml/min) with warmed (30 1C) oxygenated
(95% O2/5% CO2) artificial cerebrospinal fluid containing
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124mM NaCl, 4.4mM KCl, 25mM Na2HCO3, 1mM NaH2PO4,
1.2mM MgSO4, 2mM CaCl2 and 10mM glucose. Low-resistance
glass microelectrodes (5–10MO) filled with artificial cerebrospinal
fluid were placed into the stratum radiatum of the hippocampal
CA1 region to record field excitatory postsynaptic potentials
evoked by presynaptic stimulation pulses delivered once every
50 s to the Schaeffer collateral/commissural fibres through a
bipolar nichrome wire stimulating electrode. The magnitude of the
postsynaptic field excitatory postsynaptic potentials was measured
using the initial slope of the field excitatory postsynaptic
potentials. After a 20min period of baseline recording, LTP was
induced using either a high-frequency stimulation protocol (two
trains of 100Hz stimulation, each 1 s in duration and separated by
10 s) or a low-frequency stimulation protocol consisting of 900
stimulation pulses delivered at 5Hz.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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